These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11572632)

  • 1. Immunity to polyoma virus infection and tumorigenesis.
    Moser JM; Lukacher AE
    Viral Immunol; 2001; 14(3):199-216. PubMed ID: 11572632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.
    Kemball CC; Lee ED; Vezys V; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2005 Jun; 174(12):7950-60. PubMed ID: 15944301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.
    Byers AM; Andrews NP; Lukacher AE
    J Immunol; 2006 May; 176(10):6121-9. PubMed ID: 16670321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.
    Moser JM; Altman JD; Lukacher AE
    J Exp Med; 2001 Mar; 193(5):595-606. PubMed ID: 11238590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
    Moser JM; Gibbs J; Jensen PE; Lukacher AE
    Nat Immunol; 2002 Feb; 3(2):189-95. PubMed ID: 11812997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.
    Byers AM; Kemball CC; Moser JM; Lukacher AE
    J Immunol; 2003 Jul; 171(1):17-21. PubMed ID: 12816977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.
    Kemball CC; Lee ED; Szomolanyi-Tsuda E; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2006 Feb; 176(3):1814-24. PubMed ID: 16424212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.
    Kemball CC; Szomolanyi-Tsuda E; Lukacher AE
    J Virol; 2007 Dec; 81(24):13743-53. PubMed ID: 17913814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against polyoma virus-induced tumors is perforin-independent.
    Byers AM; Hadley A; Lukacher AE
    Virology; 2007 Feb; 358(2):485-92. PubMed ID: 17011010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoma tumor development in neonatally polyoma-virus-infected CD4-/- and CD8-/- single knockout and CD4-/-8-/- double knockout mice.
    Berke Z; Wen T; Klein G; Dalianis T
    Int J Cancer; 1996 Jul; 67(3):405-8. PubMed ID: 8707416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogen-host standoff: immunity to polyomavirus infection and neoplasia.
    Lukacher AE
    Immunol Res; 2004; 29(1-3):139-50. PubMed ID: 15181277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early virus-associated bystander events affect the fitness of the CD8 T cell response to persistent virus infection.
    Andrews NP; Pack CD; Vezys V; Barber GN; Lukacher AE
    J Immunol; 2007 Jun; 178(11):7267-75. PubMed ID: 17513776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-microglobulin knockout mice are highly susceptible to polyoma virus tumorigenesis.
    Drake DR; Lukacher AE
    Virology; 1998 Dec; 252(1):275-84. PubMed ID: 9875336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.
    Swanson PA; Hofstetter AR; Wilson JJ; Lukacher AE
    J Immunol; 2009 May; 182(9):5198-202. PubMed ID: 19380764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion.
    Wilson JJ; Pack CD; Lin E; Frost EL; Albrecht JA; Hadley A; Hofstetter AR; Tevethia SS; Schell TD; Lukacher AE
    J Immunol; 2012 May; 188(9):4340-8. PubMed ID: 22447978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
    Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
    J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection.
    Kemball CC; Pack CD; Guay HM; Li ZN; Steinhauer DA; Szomolanyi-Tsuda E; Lukacher AE
    J Immunol; 2007 Jul; 179(2):1113-21. PubMed ID: 17617604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased.
    Heidari S; Berke Z; Berglöf A; Woldegiorgis A; Smith CI; Dalianis T
    In Vivo; 1999; 13(6):439-44. PubMed ID: 10757034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.